Sign up
Quantellect · Congress · Trade Detail
NYSE: BMYBristol-Myers Squibb Company
DemocratHouse

Gilbert Ray Cisneros, Jr. bought Bristol-Myers Squibb Company (NYSE: BMY)

Gilbert Ray Cisneros, Jr. (D-CA), a U.S. Representative, has disclosed 9 trades in Bristol-Myers Squibb Company (BMY) since 2019, 5 purchases and 4 sales, worth an estimated $72K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Gilbert Ray Cisneros, Jr. bought $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on November 12, 2025. Since that trade, BMY is up +31.43% against the S&P 500 up +7.35%, an outperformance of +24.08%.

Across these filings, Gilbert Ray Cisneros, Jr. has been a net buyer of BMY (a buy-to-sell ratio of 1.25). The most recent disclosed BMY transaction shown was dated December 19, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BMY trades
9
Disclosed Vol
$72K
Buys
5
56%
Sells
4
44%
Buy / Sell
1.25
ratio
First → Last
2019–2025

Gilbert Ray Cisneros, Jr.'s BMY trades vs the price

BMY is up +31.43% since Gilbert Ray Cisneros, Jr. bought on November 12, 2025, versus +7.35% for the S&P 500.

Performance since this trade

Price change since trade
+31.43%
S&P 500 change since trade
+7.35%
Outperformance vs S&P 500
+24.08%

All Gilbert Ray Cisneros, Jr. BMY trades

TradedTypeSizeReturnEst. profit
December 19, 2025BUY$53.01+19.03%+$1K
November 12, 2025BUY$48.01+31.43%+$2K
October 9, 2025SELL$43.71+44.37%
March 18, 2020SELL$39.52+59.66%
January 14, 2020BUY$52.26+20.73%-$402
November 26, 2019SELL$44.31+42.39%
August 14, 2019BUY$35.35+78.48%+$3K
May 9, 2019SELL$36.26+74.00%
April 23, 2019BUY$34.80+81.33%+$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Gilbert Ray Cisneros, Jr. & BMY trading FAQ

Is it legal for Gilbert Ray Cisneros, Jr. to trade Bristol-Myers Squibb Company (BMY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Gilbert Ray Cisneros, Jr. buy BMY?

Gilbert Ray Cisneros, Jr. disclosed a purchase of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on November 12, 2025, according to public STOCK Act filings.

How has BMY performed since Gilbert Ray Cisneros, Jr.'s trade?

Since Gilbert Ray Cisneros, Jr. bought BMY on November 12, 2025, the stock is up +31.43%, versus +7.35% for the S&P 500 over the same period, an outperformance of +24.08%.

How many times has Gilbert Ray Cisneros, Jr. traded BMY?

Gilbert Ray Cisneros, Jr. has disclosed 9 BMY trades since 2019 (5 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BMY trades?

Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.

Gilbert Ray Cisneros, Jr.'s BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyGilbert Ray Cisneros, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.